{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T16:11:18Z","timestamp":1698336678189},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":6551,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1995,4]]},"abstract":"<jats:p><jats:italic>In the management of wounds, sometimes it is recommended to give an adult\u2010type tetanus\u2014diphtheria (Td) vaccine dose plus tetanus immune globulin (TIG). Sixty and 59 healthy young adults previously immunized against tetanus (T) and diphtheria (D) were randomized to receive intramuscularly either Td vaccine alone (group 1) or Td vaccine plus 500 IU of TIG (group 2) simultaneously. Antitoxin response was assessed after 4 weeks and 4 months. Circulating antibodies were measured by enzyme\u2010linked immunosorbent assay (ELISA). The cutoff of these tests was 0.1 IU\/mL. Titers of 0.1 IU\/mL or greater were considered protective. For geometric mean titers (GMT), antibody titers below the cutoff of the assay were given, arbitrarily, 0.05 IU\/mL. At 4 weeks, 98% or more of the subjects in group 1 had circulating T and D antitoxin levels of 0.1 IU\/mL or higher; in group 2, 95% and 90% of the subjects had titers above this limit for T and D, respectively. At 4 months, these percentages were 98% and 95% for T antitoxin levels in groups 1 and 2, respectively; whereas 96% and 88% of the subjects in groups 1 and 2 had D antitoxin levels of 0.1 IU\/mL or higher, respectively. Significantly<\/jats:italic> (P &lt; <jats:italic>.05) higher GMTs were seen at the 4\u2010week assessment (but not at 4 months) in group 1, as compared with group 2, in both T and D antitoxin levels (9.91 IU\/mL versus 5.60 IU\/mL for T antitoxin, and 2.86 IU\/mL versus 1.45 IU\/mL for D antitoxin). This finding resulted from those participants with low (&lt;0.1 IU\/mL) prevaccination antibody titers. Among these, D antibody GMTs at 4 weeks were 1.94 IU\/mL and 1.06 IU\/mL for those receiving Td vaccine or Td vaccine plus TIG, respectively; corresponding values for T antibody GMTs at 4 months were 3.53 IU\/mL and 0.64 IU\/mL<\/jats:italic> (P = <jats:italic>.02), respectively. Concurrent administration of TIG with Td vaccine interferes with the immune response to T toxoid in subjects with low prevaccination antibody titers. Further studies are needed to confirm these results<\/jats:italic>.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1995.tb04083.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T19:11:10Z","timestamp":1362769870000},"page":"420-425","source":"Crossref","is-referenced-by-count":7,"title":["Does Tetanus Immune Globulin Interfere with the Immune Response to Simultaneous Administration of Tetanus\u2014Diphtheria Vaccine? A Comparative Clinical Trial in Adults"],"prefix":"10.1002","volume":"35","author":[{"given":"Rafael","family":"Dal\u2010R\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Lasheras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"issue":"12","key":"e_1_2_1_2_2","first-page":"16","article-title":"Recommendations of the Immunization Practices Advisory Committee (ACIP). Update on Adult Immunization","volume":"40","author":"ACIP","year":"1991","journal-title":"MMWR"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6132.249-a"},{"key":"e_1_2_1_4_2","first-page":"219","article-title":"Revaccination of adults against diphtheria II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination","volume":"94","author":"Simonsen O","year":"1986","journal-title":"Acta Path Microbiol Immunol Scand"},{"key":"e_1_2_1_5_2","first-page":"6","article-title":"Prevalencia de anticuerpos antitet\u00e1nicos en la poblaci\u00f3n adulta en Catalu\u00f1a","volume":"99","author":"Vidal J","year":"1992","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6148.1371-c"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91675-7"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548609032331"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548609032332"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90235-P"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801073180108"},{"key":"e_1_2_1_12_2","first-page":"301","article-title":"Diphtheria. Two recent incidents. United Kingdom","volume":"68","author":"Anonymous.","year":"1993","journal-title":"Weekly Epidemiol Rec"},{"key":"e_1_2_1_13_2","first-page":"338","article-title":"Tetanos del adulto: mortalidad. Estudio en 130 casos","volume":"8","author":"Ramirez R","year":"1990","journal-title":"Enf Infecc Microbiol Clin"},{"key":"e_1_2_1_14_2","first-page":"1842","volume-title":"Principles and Practices of Infectious Diseases","author":"Cate TR","year":"1990"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198309153091104"},{"key":"e_1_2_1_16_2","first-page":"438","volume-title":"Vademecum Internacional","author":"Anonymous","year":"1993"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/jcm.20.4.772-774.1984","article-title":"Immunoenzymatic assay of anti\u2010diphtheria toxin antibodies in human serum","volume":"20","author":"Camargo ME","year":"1984","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-1157(83)80038-9"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92284-M"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-25-4-279"},{"key":"e_1_2_1_21_2","first-page":"123","volume-title":"Clinical Trials. A Practical Approach.","author":"Pocock SJ","year":"1990"},{"key":"e_1_2_1_22_2","volume-title":"Practical Statistics for Medical Research.","author":"Altman DG.","year":"1991"},{"issue":"1891","key":"e_1_2_1_23_2","first-page":"113","article-title":"Vigilancia epidemiol\u00f3gica de la difteria","author":"Anonymous","year":"1991","journal-title":"Bolet\u00edn Epidemiol\u00f3gico Semanal"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92383-9"},{"key":"e_1_2_1_25_2","first-page":"577","volume-title":"Harrison's Principles of Internal Medicine","author":"Abruytyn E","year":"1991"},{"key":"e_1_2_1_26_2","first-page":"509","volume-title":"Harrison's Principles of Internal Medicine","author":"Holmes RK","year":"1991"},{"key":"e_1_2_1_27_2","first-page":"1663","volume-title":"Drug Evaluations Annual 1991.","author":"American Medical Association","year":"1991"},{"key":"e_1_2_1_28_2","first-page":"1574","volume-title":"Principles and Practices of Infectious Diseases","author":"MacGregor RB","year":"1990"},{"key":"e_1_2_1_29_2","first-page":"1278","volume-title":"The Extra Pharmacopoeia","author":"Reynolds JEF","year":"1993"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196601272740404"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1995.tb04083.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1995.tb04083.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T01:08:48Z","timestamp":1698282528000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1995.tb04083.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1002\/j.1552-4604.1995.tb04083.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1995.tb04083.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}